Insider Transactions in Q4 2020 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Dustin S Sjuts President |
BUY
Other acquisition or disposition
|
Direct |
348
+0.76%
|
$7,308
$21.36 P/Share
|
|
Dec 31
2020
|
Tobin Schilke CFO |
BUY
Other acquisition or disposition
|
Direct |
493
+1.0%
|
$10,353
$21.36 P/Share
|
|
Dec 30
2020
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-6.49%
|
$894,213
$27.82 P/Share
|
|
Dec 15
2020
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-1.23%
|
$14,612
$26.75 P/Share
|
|
Dec 15
2020
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-3.12%
|
$40,456
$26.75 P/Share
|
|
Nov 30
2020
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-6.09%
|
$761,737
$23.85 P/Share
|
|
Oct 29
2020
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-5.74%
|
$861,094
$26.15 P/Share
|
|
Oct 13
2020
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
66,106
-7.91%
|
$1,784,862
$27.62 P/Share
|